HSPA2 and colorectal carcinoma: We further grouped CRC specimens based on HSP70-2 IRS, group I, low HSP70-2 IRS (<50 % tumor cells expressing HSP70-2) and group II, high HSP70-2 IRS (>50 % tumor cells expressing HSP70-2).